SNGX Insider Transactions
122 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
SNGX insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 2025-10-02 | Purchase | 15,132.0 | $1.32 |
| Straube Richard | SENIOR VICE PRESIDENT AND CMO | 2022-05-18 | Purchase | 8,000.0 | $0.5 |
| SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 2022-05-18 | Purchase | 20,000.0 | $0.44 |
| SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 2021-12-17 | Purchase | 7,000.0 | $0.74 |
| Guarino Jonathan L. | Senior Vice President and CFO | 2021-12-15 | Purchase | 1,000.0 | $0.7 |
| Guarino Jonathan L. | Senior Vice President and CFO | 2021-12-14 | Purchase | 10,000.0 | $0.71 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2021-12-14 | Purchase | 10,000.0 | $0.73 |
| ZELDIS JEROME B | Director | 2021-05-14 | Sale | 3,000.0 | $0.9 |
| ZELDIS JEROME B | Director | 2021-05-14 | Purchase | 3,000.0 | $0.89 |
| ZELDIS JEROME B | Director | 2019-11-19 | Purchase | 2,000.0 | $0.93 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2019-11-19 | Purchase | 10,770.0 | $0.93 |
| Parks Diane L. | Director | 2019-09-23 | Purchase | 14,940.0 | $0.93 |
| ZELDIS JEROME B | Director | 2019-09-19 | Purchase | 4,000.0 | $0.94 |
| ZELDIS JEROME B | Director | 2019-04-22 | Purchase | 10,000.0 | $0.73 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2019-04-22 | Purchase | 5,000.0 | $0.72 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2018-10-18 | Purchase | 8,700.0 | $1.17 |
| Pearson Mark E. | Director | 2018-10-17 | Purchase | 170,000.0 | $1.16 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2018-08-22 | Purchase | 3,530.0 | $1.42 |
| Essetifin SPA | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| CAVAZZA PAOLO | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| Leadiant Biosciences, Inc. | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| Cavazza Francesca | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| Cavazza Silvia | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| Cavazza Enrico | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| Cavazza Preta Martina | Other | 2017-11-29 | Purchase | 16,416.0 | $2.12 |
| Essetifin SPA | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| CAVAZZA PAOLO | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| Leadiant Biosciences, Inc. | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| Cavazza Francesca | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| Cavazza Silvia | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| Cavazza Enrico | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| Cavazza Preta Martina | Other | 2017-11-29 | Sale | 16,416.0 | $2.12 |
| Essetifin SPA | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| CAVAZZA PAOLO | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| Leadiant Biosciences, Inc. | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| Cavazza Francesca | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| Cavazza Silvia | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| Cavazza Enrico | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| Cavazza Preta Martina | Other | 2017-11-29 | Purchase | 5,954.0 | $2.12 |
| Essetifin SPA | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| CAVAZZA PAOLO | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| Leadiant Biosciences, Inc. | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| Cavazza Francesca | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| Cavazza Silvia | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| Cavazza Enrico | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| Cavazza Preta Martina | Other | 2017-11-29 | Sale | 5,954.0 | $2.12 |
| Essetifin SPA | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| CAVAZZA PAOLO | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| Leadiant Biosciences, Inc. | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| Cavazza Francesca | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| Cavazza Silvia | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| Cavazza Enrico | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| Cavazza Preta Martina | Other | 2017-11-29 | Purchase | 271,140.0 | $2.12 |
| Essetifin SPA | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| CAVAZZA PAOLO | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| Leadiant Biosciences, Inc. | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| Cavazza Francesca | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| Cavazza Silvia | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| Cavazza Enrico | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| Cavazza Preta Martina | Other | 2017-11-29 | Sale | 271,140.0 | $2.12 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-08 | Sale | 1,881.0 | $2.54 |
| INTREXON CORP | TenPercentOwner | 2017-05-08 | Sale | 1,881.0 | $2.54 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-08 | Sale | 9,695.0 | $2.54 |
| INTREXON CORP | TenPercentOwner | 2017-05-08 | Sale | 9,695.0 | $2.54 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-05 | Sale | 13,893.0 | $2.7 |
| INTREXON CORP | TenPercentOwner | 2017-05-05 | Sale | 13,893.0 | $2.7 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-05 | Sale | 71,607.0 | $2.7 |
| INTREXON CORP | TenPercentOwner | 2017-05-05 | Sale | 71,607.0 | $2.7 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-04 | Sale | 2,278.0 | $2.97 |
| INTREXON CORP | TenPercentOwner | 2017-05-04 | Sale | 2,278.0 | $2.97 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-04 | Sale | 11,739.0 | $2.97 |
| INTREXON CORP | TenPercentOwner | 2017-05-04 | Sale | 11,739.0 | $2.97 |
| KIRK RANDAL J | TenPercentOwner | 2017-05-04 | Sale | 49,875.0 | $4.01 |
| INTREXON CORP | TenPercentOwner | 2017-05-04 | Sale | 49,875.0 | $4.01 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2016-12-16 | Purchase | 15,804.0 | $3.16 |
| RUBIN ROBERT J. | Director | 2016-12-16 | Purchase | 3,165.0 | $3.16 |
| Brughera Marco Maria | Director | 2016-12-16 | Purchase | 2,000.0 | $3.16 |
| ZELDIS JEROME B | Director | 2015-12-23 | Purchase | 2,500.0 | $1.27 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2015-12-22 | Purchase | 10,000.0 | $1.29 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2014-12-22 | Purchase | 8,265.0 | $1.21 |
| Warusz Joseph Michael | VP of Finance/Acting CFO | 2014-12-22 | Purchase | 8,265.0 | $1.21 |
| ZELDIS JEROME B | Director | 2013-06-25 | Purchase | 23,809.0 | $1.05 |
| SCHABER CHRISTOPHER J | Chairman, CEO and President | 2013-06-25 | Purchase | 9,523.0 | $1.05 |
| Brownlie Keith L | Director | 2013-06-25 | Purchase | 19,047.0 | $1.05 |
| SCHABER CHRISTOPHER J | Chairman CEO and President | 2012-04-10 | Purchase | 9,900.0 | $0.51 |
| Mintz Hal | TenPercentOwner | 2010-08-18 | Sale | 192,314.0 | $0.24 |
| Berman Ross | TenPercentOwner | 2010-08-18 | Sale | 192,314.0 | $0.24 |
| BAM Management LLC | TenPercentOwner | 2010-08-18 | Sale | 192,314.0 | $0.24 |
| Mintz Hal | TenPercentOwner | 2010-08-18 | Purchase | 160,000.0 | $0.24 |
| Berman Ross | TenPercentOwner | 2010-08-18 | Purchase | 160,000.0 | $0.24 |
| BAM Management LLC | TenPercentOwner | 2010-08-18 | Purchase | 160,000.0 | $0.24 |
| LAPOINTE ANTHONY GREGG | Director | 2010-06-18 | Purchase | 975,610.0 | $0.21 |
| RUBIN ROBERT J. | Director | 2010-06-18 | Purchase | 243,902.0 | $0.21 |
| CAVAZZA CLAUDIO | TenPercentOwner | 2010-06-18 | Purchase | 8,608,580.0 | $0.21 |
| CAVAZZA PAOLO | TenPercentOwner | 2010-06-18 | Purchase | 2,926,829.0 | $0.21 |
| CAVAZZA PAOLO | TenPercentOwner | 2010-06-18 | Purchase | 8,608,580.0 | $0.21 |
| SIGMA TAU FINANZIARIA SPA | TenPercentOwner | 2010-06-18 | Purchase | 8,608,580.0 | $0.21 |
| SIGMA TAU INTERNATIONAL SA | TenPercentOwner | 2010-06-18 | Purchase | 8,608,580.0 | $0.21 |
| Sigma-Tau Pharmaceuticals, Inc. | TenPercentOwner | 2010-06-18 | Purchase | 8,608,580.0 | $0.21 |
| Sigma-Tau America S.A. | TenPercentOwner | 2010-06-18 | Purchase | 8,608,580.0 | $0.21 |